Dong-A breaks ground for new plant

Published: 2012-10-04 06:57:00

Updated: 2012-10-04 06:57:00

Korea’s No.1 pharmaceutical company Dong-A Pharm broke ground on Thursday to produce biosimilars in Songdo, Incheon, marking the company’s first step toward fostering biosimilars as a new growth engine.

The ground-breaking ceremony in Incheon’s free economic zone was attended by 100 officials ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK